Abstract
Glutathione S-transferase T1 (GSTT1) polymorphic variation has been implicated as a risk factor for various cancers. However, previous studies investigating the association between GSTT1 null genotype and laryngeal cancer risk in Asians reported conflicting outcomes. In the present study, the possible association of laryngeal cancer risk with GSTT1 null genotype was explored by a meta-analysis. Relevant studies were identified through a systemic search of PubMed and Chinese National Knowledge Infrastructure databases. Six studies with a total of 1,824 individuals were included in the meta-analysis. The pooled odds ratio (OR) with 95 % confidence interval (CI) was used to assess the association. Meta-analysis of all included studies showed that there was an obvious association between GSTT1 null genotype and laryngeal cancer risk in Asians (OR = 2.41, 95 % CI 1.27–4.57, P = 0.007, I 2 = 86 %). After adjusting for heterogeneity, there was still an obvious association between GSTT1 null genotype and laryngeal cancer risk in Asians (OR = 1.75, 95 % CI 1.36–2.24, P < 0.001, I 2 = 0 %). The findings from the meta-analysis suggest that GSTT1 null genotype is associated with laryngeal cancer risk in Asians.
Similar content being viewed by others
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
Beitler JJ, Muller S, Grist WJ, Corey A, Klein AM, Johns MM, et al. Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy. J Clin Oncol. 2010;28:2318–22.
Wolf GT. Routine computed tomography scanning for tumor staging in advanced laryngeal cancer: implications for treatment selection. J Clin Oncol. 2010;28:2315–7.
Sasaki CT, Jassin B. Cancer of the pharynx and larynx. Am J Med. 2001;111(Suppl 8A):118S–23.
Manjarrez ME, Ocadiz R, Valle L, Pacheco C, Marroquin A, De la Torre C, et al. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors. Clin Cancer Res. 2006;12:6946–51.
Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, et al. Regulation of the cell cycle gene, btg2, by mir-21 in human laryngeal carcinoma. Cell Res. 2009;19:828–37.
Ying XJ, Dong P, Shen B, Xu CZ, Xu HM, Zhao SW. Glutathione S-transferase m1 gene polymorphism and laryngeal cancer risk: a meta-analysis. PLoS One. 2012;7:e42826.
Lacko M, Voogd AC, Roelofs HM, Te Morsche RH, Ophuis MB, Peters WH, et al. Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk. Head Neck. 2013;35:858–67.
Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev. 2011;43:138–51.
Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal. 2004;6:289–300.
Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.
Hong YJ, Lee JK, Lee GH, Hong SI. Influence of glutathione S-transferase M1 and T1 genotypes on larynx cancer risk among Korean smokers. Clin Chem Lab Med. 2000;38:917–9.
Li Q, Wang L, Chen Y, Du Y, Kong P, Li Y, et al. Polymorphisms of gstm1, gstt1 and susceptibility of laryngeal and hypopharyngeal carcinomas. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;23:1105–7. 1111.
Nosheen M, Ishrat M, Malik FA, Baig RM, Kayani MA. Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev. 2010;11:881–5.
Ruwali M, Singh M, Pant MC, Parmar D. Polymorphism in glutathione S-transferases: susceptibility and treatment outcome for head and neck cancer. Xenobiotica. 2011;41:1122–30.
Tian S, Zhang J, Xiao Q, Zhai J, Yan X, Huang M, et al. [The association between genetic polymorphisms of gstm1, gstt1, gstp1 and susceptibility to laryngeal carcinoma from the Han people in Guangdong zone]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;25:204–10.
Masood N, Kayani MA. Protection against laryngeal and pharyngeal carcinoma: heterozygous vs. homozygous deletions of GSTM1 and GSTT1. Genet Mol Biol. 2013;36:1–6.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Ying XJ, Dong P, Shen B, Wang J, Wang S, Wang G. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. J Cancer Res Clin Oncol. 2011;137:1661–7.
Dong G, Tian Y, Chen S, Xu X, Zheng J, Li T. Glutathione S-transferase T1 null genotype is associated with oral cancer susceptibility in Asian populations. Tumour Biol. 2013;34:1753–7.
Zhao Y, Luo Y, Huang B, Qin B, Zhang T, Zhang J, et al. Gstt1 null genotype contributes to increased risk of gastric cancer in Chinese population: evidence from a meta-analysis. Tumour Biol. 2013;34:1691–7.
Ying XJ, Xu CZ, Xu HM, Sun ZF, Zhang J, Wang GL, et al. Lack of association between glutathione S-transferase T1 gene polymorphism and laryngeal cancer susceptibility: a meta-analysis based on 2,124 cases and 2,059 controls. Gene. 2012;494:11–6.
Acknowledgments
We are indebted to the authors of the primary studies.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Q., Liu, M. Glutathione S-transferase T1 null genotype and laryngeal cancer risk: a meta-analysis. Tumor Biol. 35, 8781–8785 (2014). https://doi.org/10.1007/s13277-014-2121-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-014-2121-8